These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23889283)

  • 1. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome.
    Durbán A; Abellán JJ; Jiménez-Hernández N; Artacho A; Garrigues V; Ortiz V; Ponce J; Latorre A; Moya A
    FEMS Microbiol Ecol; 2013 Dec; 86(3):581-9. PubMed ID: 23889283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
    BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.
    Rangel I; Sundin J; Fuentes S; Repsilber D; de Vos WM; Brummer RJ
    Aliment Pharmacol Ther; 2015 Nov; 42(10):1211-21. PubMed ID: 26376728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.
    Mättö J; Maunuksela L; Kajander K; Palva A; Korpela R; Kassinen A; Saarela M
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):213-22. PubMed ID: 15747442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
    Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
    World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
    Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
    Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.
    Carroll IM; Ringel-Kulka T; Keku TO; Chang YH; Packey CD; Sartor RB; Ringel Y
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G799-807. PubMed ID: 21737778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
    Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
    Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
    Krogius-Kurikka L; Lyra A; Malinen E; Aarnikunnas J; Tuimala J; Paulin L; Mäkivuokko H; Kajander K; Palva A
    BMC Gastroenterol; 2009 Dec; 9():95. PubMed ID: 20015409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression.
    Liu Y; Zhang L; Wang X; Wang Z; Zhang J; Jiang R; Wang X; Wang K; Liu Z; Xia Z; Xu Z; Nie Y; Lv X; Wu X; Zhu H; Duan L
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1602-1611.e5. PubMed ID: 27266978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.
    Andrews CN; Griffiths TA; Kaufman J; Vergnolle N; Surette MG; Rioux KP
    Aliment Pharmacol Ther; 2011 Aug; 34(3):374-83. PubMed ID: 21671966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
    Ahluwalia B; Iribarren C; Magnusson MK; Sundin J; Clevers E; Savolainen O; Ross AB; Törnblom H; Simrén M; Öhman L
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiota and irritable bowel syndrome].
    Ducrotté P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S52-6. PubMed ID: 20889005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.
    Codling C; O'Mahony L; Shanahan F; Quigley EM; Marchesi JR
    Dig Dis Sci; 2010 Feb; 55(2):392-7. PubMed ID: 19693670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
    Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
    Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
    Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
    Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.